Condition: Peripheral Intravenous Vein Catheter Phlebitis · Intravenous Infection · Sponsor: Corewell Health East
This is a prospective, parallel, non-blinded, two-arm randomized controlled trial of intravenous catheter failure evaluating the impact of a built-in guide wire. The objective of this study is to demonstrate that the control ultralong intravenous catheter (IV) without the guide wire is non-inferior to the experimental catheter with the guide wire. After obtaining consent, eligible patients will be randomly allocated to control Arm 1 (ultralong intravenous catheter) or experimental Arm 2 (ultralong intravenous catheter with guide wire) in a ratio of 1:1 via a computer-generated randomization schedule. The participants will be followed to collect data until the catheter is removed.
This description comes directly from the study's public registry record.
Amit Bahl, MD · 248-898-9111 · amit.bahl@corewellhealth.org
Maureen Cooney, RN · 248-551-0099 · maureen.cooney@corewellhealth.org
Always discuss trial participation with your own doctor first.
| Beaumont Hospital - Royal Oak | Royal Oak, Michigan, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06107361